Skip to main content

Monsanto’s Summary Judgment Motion Rejected By MDL Judge

Monsanto’s Summary Judgment Motion Rejected By MDL Judge

Monsanto’s Summary Judgment Motion Rejected By MDL Judge

Introduction

In a pretrial order issued on March 7, U.S. District Judge Vince Chhabria rejected a motion for summary judgment filed by Monsanto to escape a series of bellwether cases lined up against it over the hazards of the controversial weed killer, Roundup.

Judge Chhabria indicated that the claims filed against Monsanto would continue and the agro-giant must bear punitive damages if the plaintiffs successfully prove that glyphosate exposure from Roundup herbicide caused their cancer. The judge opined, if the plaintiffs establish the causation, Monsanto will be liable for withholding safety warnings. Judge Chhabria further stated, "although the evidence that Roundup causes cancer is quite equivocal, there is strong evidence from which a jury could conclude that Monsanto does not particularly care whether its product is, in fact, giving people cancer, focusing instead on manipulating public opinion and undermining anyone who raises genuine and legitimate concerns about the issue.” The judge rejected Monsanto's arguments that the evidence presented was insufficient to support a punitive damages award.

The federal bellwether trial developments over glyphosate exposure and cancer are closely observed by other plaintiffs and lawyers, as Monsanto is charged with more than 10,000 other Roundup lawsuits over allegations that it failed to take adequate measures to forewarn about glyphosate exposure risks.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to New $7.4B Opioid Settlement

Categories: Opioids

All 50 U.S. states, along with the District of Columbia and U.S. territories, have agreed to a $7.4 billion settlement with Purdue Pharma, the manufacturer of OxyContin.

This deal addresses allegations that the company’s aggressive and…

Oregon to Get $66M in Sackler Opioid Settlement

Categories: Opioids

Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!